CID 3001831

Tuberactinamine n

Structural Information

Molecular Formula
C19H31N11O8
SMILES
C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)N)N
InChI
InChI=1S/C19H31N11O8/c20-7-3-24-17(37)12(8-1-2-23-18(21)29-8)30-14(34)9(4-25-19(22)38)26-15(35)11(6-32)28-16(36)10(5-31)27-13(7)33/h4,7-8,10-12,31-32H,1-3,5-6,20H2,(H,24,37)(H,26,35)(H,27,33)(H,28,36)(H,30,34)(H3,21,23,29)(H3,22,25,38)/b9-4-
InChIKey
LIFZJBQBBQFSKX-WTKPLQERSA-N
Compound name
[(Z)-[15-amino-3-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-6-ylidene]methyl]urea
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

541.2357 Da
Monoisotopic Mass

-6.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 542.24298 230.2
[M+Na]+ 564.22492 228.4
[M-H]- 540.22842 211.7
[M+NH4]+ 559.26952 224.1
[M+K]+ 580.19886 216.1
[M+H-H2O]+ 524.23296 202.3
[M+HCOO]- 586.23390 225.9
[M+CH3COO]- 600.24955 229.9
[M+Na-2H]- 562.21037 233.9
[M]+ 541.23515 228.2
[M]- 541.23625 228.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.